References
- Besson C, Goubar A, Gabarre J, et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood. 2001;98:2339–2344.
- Bohlius J, Schmidlin K, costagliola D, et al. Incidence and risk factors of HIV-related non-Hodgkin’s lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antiviral Ther. 2009;14:1065–1074.
- Navarro JT, Lloveras N, Ribera JM, et al. The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy. Haematologica. 2005;90:704–706.
- British HIV. Association guidelines for HIV-Associated malignancies for 2014. HIV Med. 2014;15(Suppl 2):1–92.
- Powles T, Imami N, Nelson M, et al. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma. AIDS. 2002;16:531–536.
- Stellbrink H, Baldus S, Behrens G, et al. HIV induced immune activation – pathogenesis and clinical relevance. Eur J Med Res. 2010;15:1–12.
- Parker A, Bowles K, Bradley J, et al. Writing group on behalf of the haemato-oncology task force of the British Society for Standards in Haematology and British Transplantation Society; management of post transplant lymphoproliferative disorder in adult solid organ transplant recipients – BCSH and BTS guidelines. Br J Haematol. 2010;149:693–705.
- Gottschalk S, Rooney C, Heslop H. Post-transplant lymphoproliferative disorders. Annu Rev Med. 2005;56:29–44.
- Walker N, Scriven J, Meintjes G, Wilkinson R. Immune reconstitution inflammatory syndrome in HIV-infected patients. HIV/AIDS Res Palliat Care. 2015;7:49–64.
- Gopal S, Patel M, Achenbach C, et al. Lymphoma immune reconstitution in the centre for AIDS research network of integrated clinical systems cohort. HIV/AIDS. 2014;59:279–286.
- Fätkenheuer G, Hell K, Roers A, et al. Spontaneous regression of HIV associated T-cell non-Hodgkin’s lymphoma with highly active antiretroviral therapy. Eur J Med Res. 2000;5:236–240.
- Baraboutis IG, Marinos L, Lekakis LJ, et al. Long-term complete regression of nodal marginal zone lymphoma transformed into diffuse large B-cell lymphoma with highly active antiretroviral therapy alone in human immunodeficiency virus infection. Am J Med Sci. 2009;338:517–521.
- Amengual J, Zhang X, Ibrahim S, et al. Regression of HIV-related diffuse large B-cell lymphoma in response to antiviral therapy alone. Blood. 2008;112:4359–4360.
- Bower M, Fisher M, Hill T, et al. Sabin C for the UK CHIC Steering Committee. CD4 counts and the risk of systemic non-Hodgkin’s lymphoma in individuals with HIV in the UK. Haematologica. 2009;94:875–880.
- Smith J, Sabin C, Youle M, et al. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy. J Infect Dis. 2004;190:1860–1868.